Diseases of the Nervous System | Mental Health & Behavioral Research, Phase II

A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of SPN-817 in Adults with Focal Onset Seizures

Volunteers
Health Professionals

Ages
18 years - 70 years
Gender
Both

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Danielle Carlson

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Aline Herlopian, MD
Associate Professor Term; Affiliated Faculty , Yale Institute for Global Health; Medical Director, Clinical Neurophysiology/EEG lab, Neurology; Director, Clinical trials in Epilepsy , Neurology

Sub-Investigator

Lawrence Hirsch, MD

Last Updated
03/16/2026
Study IRB
#2000039775